Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025
상품코드:1810930
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
임상시험용 의약품 CDMO 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.7%로 성장할 전망이며, 76억 7,000만 달러로 성장이 예측됩니다. 이 예측 기간의 성장은 희귀 및 희소약 개발에 대한 중시 확대, 전임상부터 임상시험까지의 일관된 서비스에 대한 수요 증가, 생물제제 및 유전자 치료의 복잡화, 소분자의 혁신에 대한 투자 확대, 가상 파마의 비즈니스 모델 채용 확대 등에 기인하고 있습니다. 이 기간에 예상되는 주요 동향으로는 통합형 의약품 개발 플랫폼의 발전, AI를 활용한 임상시험 설계 출현, 맞춤형 의료 제조의 혁신, 규제 준수 기술의 진보, 유연한 모듈식 제조 시설의 개발 등이 있습니다.
임상시험 증가는 향후 임상시험용 의약품 CDMO 시장의 성장을 견인할 것으로 예측됩니다. 임상시험은 관리된 조건 하에서 치료, 처치, 개입의 안전성 및 효능을 평가하기 위해 인간 참가자를 포함하여 신중하게 설계된 시험입니다. 만성 질환 및 복잡한 질병이 증가함에 따라 제약 기업과 생명 공학 기업이 새로운 치료법을 개발하고 시험하며 혁신적인 치료법에 대한 수요가 증가하고 있음이 임상시험의 성장을 뒷받침하고 있습니다. 임상시험용 의약품 CDMO는 임상시험용 제제의 개발과 제조를 합리화함으로써 임상시험을 지원하고, 임상시험의 각 단계에서 임상시험약의 시기적절하고 컴플라이언스에 기반한 공급을 보장합니다. 예를 들어 영국을 거점으로 하는 업계 단체인 영국 제약공업협회는 2023년 11월 영국에서 업계 주도의 임상시험 건수가 연간 4.3% 증가했으며, 2021년 394건에서 2022년에는 411건으로 보고했습니다. 따라서 임상시험 증가는 임상시험용 의약품 CDMO 시장의 성장을 이끌고 있습니다.
임상시험용 의약품 CDMO 시장의 주요 기업은 개발 능력을 강화하고 임상시험 진입을 가속화하기 위해 전략적 파트너십에 주력하고 있습니다. 전략적 파트너십은 독립적인 운영을 유지하면서 서로의 강점, 자원 및 전문 지식을 활용하고 공통 목표를 달성하기 위해 협력하는 두 개 이상의 조직 간의 공식적인 협력 관계입니다. 예를 들어, 2023년 8월 독일의 생명과학기업인 잘트리우스 AG는 미국의 생명과학기업인 리플리젠 코퍼레이션과 제휴하여 BIOSTAT STR과 XCell ATF 기술을 결합한 업스트림 공정 강화를 위한 통합 시스템을 발표했습니다. 이 제휴는 효율성 및 확장성을 향상시켜 바이오 의약품 생산을 최적화하는 것을 목표로 합니다. 이 제휴는 바이오프로세싱 솔루션의 혁신과 바이오 매뉴팩처링 산업의 발전에 대한 잘토리우스사의 지속적인 헌신을 강조합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 임상시험용 의약품 CDMO : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 임상시험용 의약품 CDMO 시장 : 성장률 분석
세계의 임상시험용 의약품 CDMO 시장 실적 : 규모 및 성장(2019-2024년)
세계의 임상시험용 의약품 CDMO 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 임상시험용 의약품 CDMO : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 임상시험용 의약품 CDMO 시장 : 제품별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
소분자
거대분자
세계의 임상시험용 의약품 CDMO 시장 : 처방 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
고형 제제
액체 제형
주사제
세계의 임상시험용 의약품 CDMO 시장 : 서비스 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
전임상 서비스
임상시험 재료 공급
규제 서포트 서비스
제조 서비스
세계의 임상시험용 의약품 CDMO 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제약회사
생명 공학 기업
학술연구기관
기타 최종 사용자
세계의 임상시험용 의약품 CDMO 시장 : 저분자 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
합성소분자
반합성 소분자
펩티드계 소분자
올리고뉴클레오티드
세계의 임상시험용 의약품 CDMO 시장 : 대분자 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
단일클론항체(mAbs)
재조합 단백질
백신
세포 치료 제품
유전자 치료 제품
RNA 기반 치료제
제7장 지역별 및 국가별 분석
세계의 임상시험용 의약품 CDMO 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 임상시험용 의약품 CDMO 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
임상시험용 의약품 CDMO 시장 : 경쟁 구도
임상시험용 의약품 CDMO 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius Kabi AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Lonza Group Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Catalent Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Samsung Biologics Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Fareva SA
Recipharm AB
PCI Pharma Services
Vetter Pharma
Delpharm
Kindeva Drug Delivery LP
Ajinomoto Bio-Pharma Services
Cenexi SAS
Grand River Aseptic Manufacturing Inc.
INCOG BioPharma Services
Aurigene Pharmaceutical Services
Jubilant HollisterStier LLC
Symbiosis Pharmaceutical Services Ltd.
Afton Scientific Corp.
Amaran Biotech Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
임상시험용 의약품 CDMO 시장(2029년) : 새로운 기회를 제공하는 국가
임상시험용 의약품 CDMO 시장(2029년) : 새로운 기회를 제공하는 부문
임상시험용 의약품 CDMO 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
An investigational new drug contract development and manufacturing organization (CDMO) refers to a service provider that assists in the development and manufacturing of pharmaceutical compounds intended for clinical trial use under an Investigational New Drug (IND) application. These organizations operate in accordance with regulatory standards applicable to early-stage drug development, ensuring adherence to the guidelines necessary for progressing experimental therapies toward regulatory approval.
The primary products offered by investigational new drug CDMOs include small molecules and large molecules. Small molecules are low molecular weight compounds capable of easily penetrating cell membranes and interacting with intracellular targets to affect biological functions. These are developed into various formulations, such as solid, liquid, and injectable forms, and are supported by a range of services including preclinical studies, clinical trial material supply, regulatory support, and manufacturing services. The end users include pharmaceutical companies, biotechnology firms, academic and research institutions, among others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The investigational new drug contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides investigational new drug contract development and manufacturing organization (CDMO) market statistics, including investigational new drug contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with a investigational new drug contract development and manufacturing organization (CDMO) market share, detailed investigational new drug contract development and manufacturing organization (CDMO) market segments, market trends and opportunities, and any further data you may need to thrive in the investigational new drug contract development and manufacturing organization (CDMO) industry. This investigational new drug contract development and manufacturing organization (CDMO) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The investigational new drug contract development and manufacturing organization (CDMO) market size has grown strongly in recent years. It will grow from $5.53 billion in 2024 to $5.91 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to the increasing demand for early-phase clinical trials, greater outsourcing by pharmaceutical companies, a rise in the development of biologics and complex molecules, enhanced regulatory support for expedited drug approvals, and a heightened emphasis on cost-efficiency and reducing time-to-market.
The investigational new drug contract development and manufacturing organization (CDMO) market size is expected to see strong growth in the next few years. It will grow to $7.67 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to the expanding emphasis on rare and orphan drug development, the increasing demand for integrated preclinical-to-clinical services, the rising complexity of biologics and gene therapies, growing investments in small molecule innovation, and the wider adoption of virtual pharma business models. Key trends expected during this period include advancements in integrated drug development platforms, the emergence of AI-driven clinical trial designs, innovations in personalized medicine manufacturing, progress in regulatory compliance technologies, and the development of flexible, modular manufacturing facilities.
The increase in clinical trials is expected to drive the growth of the investigational new drug contract development and manufacturing organization (CDMO) market moving forward. Clinical trials are carefully designed studies involving human participants to evaluate the safety and efficacy of medical treatments, procedures, or interventions under controlled conditions. The growth in clinical trials is primarily fueled by the rising demand for innovative treatments, as escalating rates of chronic and complex diseases push pharmaceutical and biotech companies to develop and test new therapies. Investigational new drug CDMOs support clinical trials by streamlining the development and manufacturing of trial-ready drug formulations, ensuring timely and compliant supply of investigational products for each phase of the study. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported a 4.3% increase in the annual number of industry-led clinical trials in the UK, rising from 394 in 2021 to 411 in 2022. Therefore, the rise in clinical trials is driving growth in the investigational new drug CDMO market.
Key players in the investigational new drug CDMO market are focusing on strategic partnerships to enhance development capabilities and accelerate clinical trial entry. Strategic partnerships are formal collaborations between two or more organizations that work together to achieve shared goals, leveraging each other's strengths, resources, or expertise while maintaining independent operations. For instance, in August 2023, Sartorius AG, a Germany-based life sciences company, partnered with Repligen Corporation, a US-based life sciences firm, to introduce an integrated system combining the BIOSTAT STR and XCell ATF technologies for upstream process intensification. This partnership aims to optimize biopharmaceutical production by improving efficiency and scalability. The collaboration highlights Sartorius' ongoing commitment to innovation in bioprocessing solutions and advancing the biomanufacturing industry.
In January 2024, Alcami Corporation, a US-based pharmaceutical contract development and manufacturing organization (CDMO), acquired Pacific Pharmaceutical Services for an undisclosed amount. This acquisition enables Alcami to expand its presence on the West Coast and strengthen its analytical testing and quality control capabilities. Pacific Pharmaceutical Services is a US-based company specializing in pharmaceutical testing and quality assurance services.
Major players in the investigational new drug contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Fresenius Kabi AG, Lonza Group Ltd., Catalent Inc., Samsung Biologics Co. Ltd., Fareva SA, Recipharm AB, PCI Pharma Services, Vetter Pharma, Delpharm, Kindeva Drug Delivery LP, Ajinomoto Bio-Pharma Services, Cenexi SAS, Grand River Aseptic Manufacturing Inc., INCOG BioPharma Services, Aurigene Pharmaceutical Services, Jubilant HollisterStier LLC, Symbiosis Pharmaceutical Services Ltd., Afton Scientific Corp., and Amaran Biotech Inc.
North America was the largest region in the investigational new drug contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in investigational new drug contract development and manufacturing organization (CDMO) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the investigational new drug contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The investigational new drug contract development and manufacturing organization (CDMO) market includes revenues earned by entities through analytical method development, clinical trial material manufacturing, process development, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on investigational new drug contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for investigational new drug contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The investigational new drug contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Small Molecules; Large Molecules
2) By Formulation Type: Solid Formulations; Liquid Formulations; Injectable Formulations
3) By Service Type: Clinical Trial Material Supply; Regulatory Support Services; Manufacturing Services
4) By End-User: Biotechnology Companies; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Small Molecules: Synthetic Small Molecules; Semi-synthetic Small Molecules; Peptide-based Small Molecules; Oligonucleotides
2) By Large Molecules: Monoclonal Antibodies (mAbs); Recombinant Proteins; Vaccines; Cell Therapy Products; Gene Therapy Products; RNA-based Therapeutics
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Characteristics
3. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies
4. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework
5.1. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis
5.4. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)
6. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Segmentation
6.1. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Small Molecules
Large Molecules
6.2. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solid Formulations
Liquid Formulations
Injectable Formulations
6.3. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Preclinical Services
Clinical Trial Material Supply
Regulatory Support Services
Manufacturing Services
6.4. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Biotechnology Companies,
Academic And Research Institutes
Other End-Users
6.5. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Synthetic Small Molecules
Semi-synthetic Small Molecules
Peptide-based Small Molecules
Oligonucleotides
6.6. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Large Molecules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies (mAbs)
Recombinant Proteins
Vaccines
Cell Therapy Products
Gene Therapy Products
RNA-based Therapeutics
7. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis
7.1. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
8.1. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
9.1. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
9.2. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
10.1. India Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
11.1. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
11.2. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
12.1. Australia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
13.1. Indonesia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
14.1. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
14.2. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
15.1. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
15.2. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
16.1. UK Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
17.1. Germany Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
18.1. France Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
19.1. Italy Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
20.1. Spain Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
21.1. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
21.2. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
22.1. Russia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
23.1. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
23.2. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
24.1. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
24.2. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
25.1. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
25.2. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
26.1. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
26.2. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
27.1. Brazil Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
28.1. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
28.2. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
29.1. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
29.2. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles
30.1. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape
30.2. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Samsung Biologics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies
31.1. Fareva SA
31.2. Recipharm AB
31.3. PCI Pharma Services
31.4. Vetter Pharma
31.5. Delpharm
31.6. Kindeva Drug Delivery LP
31.7. Ajinomoto Bio-Pharma Services
31.8. Cenexi SAS
31.9. Grand River Aseptic Manufacturing Inc.
31.10. INCOG BioPharma Services
31.11. Aurigene Pharmaceutical Services
31.12. Jubilant HollisterStier LLC
31.13. Symbiosis Pharmaceutical Services Ltd.
31.14. Afton Scientific Corp.
31.15. Amaran Biotech Inc.
32. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
34. Recent Developments In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market
35. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies
35.1 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities
35.2 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities
35.3 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies
